TBC1D23 Inhibitors
TBC1D23 inhibitors are a class of chemical compounds that target and inhibit the function of the TBC1D23 protein, a member of the TBC1 domain family of proteins. TBC1D23 plays a critical role in intracellular trafficking, specifically in the regulation of vesicle transport and membrane trafficking processes. Unlike many other TBC1 domain proteins that serve as GTPase-activating proteins (GAPs) for Rab GTPases, TBC1D23 is unique in that it does not directly regulate Rab GTPases but acts as a linker protein between vesicles and microtubule-associated motors. It helps coordinate the movement of vesicles along microtubules by connecting the transport machinery with components like sorting nexins and other vesicle-associated proteins. Inhibition of TBC1D23 disrupts this vesicle-to-motor connection, potentially leading to alterations in vesicle positioning, cargo sorting, and cellular trafficking routes.
Research involving TBC1D23 inhibitors provides significant insights into how vesicular transport is regulated at the molecular level. By blocking TBC1D23 function, scientists can explore how intracellular transport processes are disrupted and investigate the downstream effects on cargo delivery, recycling, and endosomal trafficking. TBC1D23 inhibitors are particularly useful for examining how this protein contributes to the spatial organization of vesicles within the cell and how it regulates the interaction between vesicles and the cytoskeleton. This class of inhibitors also helps elucidate the broader regulatory networks of vesicle trafficking and sorting, highlighting the critical role of TBC1D23 in maintaining cellular architecture and intracellular communication. Through the use of these inhibitors, researchers can gain a deeper understanding of the molecular machinery involved in vesicular transport and how disruptions in these processes affect overall cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As an inhibitor of PI3K, Wortmannin can disrupt the PI3K signaling pathway, which is crucial for vesicle trafficking, where TBC1D23 is known to play a role. Inhibition of PI3K indirectly impairs TBC1D23's function in vesicular transport. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor; by inhibiting PI3K, it would disrupt the signaling necessary for vesicle formation and movement, processes in which TBC1D23 is implicated, thereby indirectly inhibiting TBC1D23's role in these pathways. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, which is involved in the scission of vesicles from the membrane. Since TBC1D23 is involved in vesicular trafficking, inhibition of dynamin would indirectly inhibit TBC1D23 by stalling vesicle transport it regulates. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Dyngo-4a is a potent dynamin inhibitor. By blocking dynamin, it would disrupt endocytosis and other trafficking processes that TBC1D23 facilitates, thereby indirectly inhibiting TBC1D23 function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules, preventing their disassembly. Microtubule dynamics are essential for vesicle transport, to which TBC1D23 contributes. Therefore, stabilization of microtubules can indirectly inhibit TBC1D23's role in vesicle trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, which are critical for vesicle transport. TBC1D23, which is involved in directing vesicle trafficking, would be functionally inhibited as microtubule disruption would impede this trafficking process. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine binds to tubulin, inhibiting microtubule assembly. As microtubule dynamics are essential for vesicular transport mechanisms, which involve TBC1D23, its function would be indirectly inhibited by preventing proper vesicle movement. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, ultimately preventing microtubule polymerization. Because microtubules are necessary for vesicle trafficking, the inhibition of their polymerization indirectly inhibits TBC1D23's function in this process. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin filaments, another component of the cytoskeleton involved in vesicle movement. TBC1D23's role in vesicle trafficking would be indirectly inhibited by the disruption of cytoskeletal dynamics necessary for vesicle motility. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers, inhibiting actin polymerization. Since actin dynamics are important for vesicle transport to which TBC1D23 contributes, this would indirectly inhibit TBC1D23 by affecting vesicle motility. | ||||||